NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, PHYSICAL EXERCISE AND GINGER SUPPLEMENTATION AS ACCESSIBLE THERAPEUTIC OPTIONS IN THE MANAGEMENT OF PRIMARY DYSMENORRHEA: A LITERATURE REVIEW
Abstract
Background: Primary dysmenorrhea (PD) constitutes the most prevalent gynecological disorder among women of reproductive age and is associated with a substantial reduction in quality of life and social functioning. While nonsteroidal anti-inflammatory drugs (NSAIDs) remain the first-line treatment due to their proven analgesic efficacy, their use may be limited by the risk of adverse effects. Consequently, increasing scientific attention has been directed toward non-pharmacological alternatives, including physical activity and ginger supplementation, which demonstrate a more favorable safety profile.
Aim: The objective of this review is to systematize and evaluate the effectiveness of physical activity, nonsteroidal anti-inflammatory drugs (NSAIDs) and ginger supplementation in the management of primary dysmenorrhea.
Material and Methods: A comprehensive literature search in PubMed was conducted. The review covered RCTs, observational studies and meta-analyses on the effects of NSAIDs, exercise and ginger on menstrual pain intensity and duration in women with primary dysmenorrhea.
Results: The analysis of current literature indicates that NSAIDs, physical activity and ginger extract each contribute to alleviating pain associated with primary dysmenorrhea. Among the interventions examined, NSAIDs demonstrated the highest short-term analgesic efficacy. Physical exercise provided comparable reductions in pain intensity and duration, with the added benefit of improved psychological well-being. Ginger significantly reduced pain symptoms and showed efficacy comparable to NSAIDs.
Conclusions: According to current guidelines, NSAIDs remain the first-line pharmacological treatment for primary dysmenorrhea due to their proven efficacy. However, regular physical activity and ginger supplementation represent safe and effective alternatives, particularly for women who experience adverse effects from NSAID use.
References
Bernardi, M., Lazzeri, L., Perelli, F., et al. (2017). Dysmenorrhea and related disorders [version 1; peer review: 3 approved]. F1000Research, 6(F1000 Faculty Rev), 1645. https://doi.org/10.12688/f1000research.11682.1
Ferries-Rowe, E., Corey, E., & Archer, J. S. (2020). Primary dysmenorrhea: Diagnosis and therapy. Obstetrics & Gynecology, 136(5), 1047–1058. https://doi.org/10.1097/AOG.0000000000004096
Gutman, G., Tassy Nunez, A., & Fisher, M. (2022). Dysmenorrhea in adolescents. Current Problems in Pediatric and Adolescent Health Care, 52(5), 101186. https://doi.org/10.1016/j.cppeds.2022.101186
Schoep, M. E., Nieboer, T. E., van der Zanden, M., Braat, D. D. M., & Nap, A. W. (2019). The impact of menstrual symptoms on everyday life: A survey among 42,879 women. American Journal of Obstetrics and Gynecology, 220(6), 569.e1–569.e7. https://doi.org/10.1016/j.ajog.2019.02.048
Donayeva, A., Samaha, I., Amanzholkyzy, A., Abdelazim, I., Nurgaliyeva, R., Gubasheva, G., Saparbayev, S. (2023). The impact of primary dysmenorrhea on adolescents’ activities and school attendance. Journal of Medicine and Life, 10(2023), 1462–1467. https://doi.org/10.25122/jml-2023-0247
Karout, S., Soubra, L., Rahme, D., Karout, L., Khojah, H. M. J., & Itani, R. (2021). Prevalence, risk factors, and management practices of primary dysmenorrhea among young females. BMC Women’s Health, 21, Article 392. https://doi.org/10.1186/s12905-021-01532-w
Li, X., [et al.] (2022). The economic burden and long term outcomes of dysmenorrhea. Value in Health. Advance online publication. https://doi.org/10.1016/j.jval.2022.03.023
Walter, S. L., & Jeve, Y. (2023). Primary dysmenorrhoea: A review of the current evidence. Obstetrics, Gynaecology & Reproductive Medicine, 33(11). https://doi.org/10.1016/j.ogrm.2023.08.003
Kho, K. A., & Shields, J. K. (2020). Diagnosis and management of primary dysmenorrhea. JAMA, 323(3), 268–269. https://doi.org/10.1001/jama.2019.16921
Weissman, A. M., Hartz, A. J., Hansen, M. D., & Johnson, S. R. (2004). The natural history of primary dysmenorrhoea: A longitudinal study. BJOG: An International Journal of Obstetrics & Gynaecology, 111(4), 345–352. https://doi.org/10.1111/j.1471-0528.2004.00090.x
Itani, R., Soubra, L., Karout, S., Rahme, D., Karout, L., & Khojah, H. M. J. (2022). Primary dysmenorrhea: Pathophysiology, diagnosis, and treatment updates. Korean Journal of Family Medicine, 43(2), 101–108. https://doi.org/10.4082/kjfm.21.0103
Burnett, M. (2025). Guideline No. 345: Primary Dysmenorrhea. Journal of Obstetrics and Gynaecology Canada, 47(5), 102840. https://doi.org/10.1016/j.jogc.2025.102840
Harel, Z. (2012). Dysmenorrhea in adolescents and young adults: An update on pharmacological treatments and management strategies. Expert Opinion on Pharmacotherapy, 13(15), 2157–2160. https://doi.org/10.1517/14656566.2012.725045
Iacovides, S., Avidon, I., & Baker, F. C. (2015). What we know about primary dysmenorrhea today: A critical review. Human Reproduction Update, 21(6), 762–778. https://doi.org/10.1093/humupd/dmv039
Dawood, M. Y. (2006). Primary dysmenorrhea: Advances in pathogenesis and management. Obstetrics & Gynecology, 108(2), 428–441. https://doi.org/10.1097/01.AOG.0000230214.26638.0c
Hayaishi, O., & Matsumura, H. (1995). Prostaglandins and sleep. Advances in Neuroimmunology, 5(2), 211–216. https://doi.org/10.1016/0960-5428(95)00010‑Y
Valentin, L., Sladkevicius, P., Kindahl, H., Broeders, A., Marsal, K., & Melin, P. (2000). Effects of a vasopressin antagonist in women with dysmenorrhea. Gynecologic and Obstetric Investigation, 50(3), 170–177. https://doi.org/10.1159/000010319
Marjoribanks, J., Proctor, M. L., & Farquhar, C. (2010). Non‑steroidal anti‑inflammatory drugs for dysmenorrhoea (Cochrane Review No. CD001751, updated ed.). Cochrane Database of Systematic Reviews, 2010(1), Article CD001751. https://doi.org/10.1002/14651858.CD001751.pub2
Gutman, G., Tassy Nunez, A., & Fisher, M. (2022, May). Dysmenorrhea in adolescents. Current Problems in Pediatric and Adolescent Health Care, 52(5), Article 101186. https://doi.org/10.1016/j.cppeds.2022.101186
Nie, W., Xu, P., Hao, C., Chen, Y., Yin, Y., & Wang, L. (2020, May). Efficacy and safety of over‑the‑counter analgesics for primary dysmenorrhea: A network meta‑analysis. Medicine, 99(19), Article e19881. https://doi.org/10.1097/MD.0000000000019881
Feng, X., & Wang, X. (2018). Comparison of the efficacy and safety of non‑steroidal anti‑inflammatory drugs for patients with primary dysmenorrhea: A network meta‑analysis. Molecular Pain, 14, Article 1744806918770320. https://doi.org/10.1177/1744806918770320
Kirsch, E., Rahman, S., Kerolus, K., Hasan, R., Kowalska, D. B., Desai, A., & Bergese, S. D. (2024). Dysmenorrhea, a narrative review of therapeutic options. Journal of Pain Research, 17, 2657–2666. https://doi.org/10.2147/JPR.S459584
Marjoribanks, J., Ayeleke, R. O., Farquhar, C., & Proctor, M. (2015). Non‐steroidal anti‐inflammatory drugs for dysmenorrhoea (Cochrane Database of Systematic Reviews, 2015(7), Article CD001751.pub3). https://doi.org/10.1002/14651858.CD001751.pub3
Zhang, W. Y., & Wan‑Po, A. L. (1998). Efficacy of minor analgesics in primary dysmenorrhoea: A systematic review. British Journal of Obstetrics and Gynaecology, 105(7), 780–789. https://doi.org/10.1111/j.1471-0528.1998.tb10210.x
Guimarães, I., & Póvoa, A. M. (2020). Primary dysmenorrhea: Assessment and treatment. Revista Brasileira de Ginecologia e Obstetrícia, 42(8), 501–507. https://doi.org/10.1055/s-0040-1712131
Kirsch, E., Rahman, S., Kerolus, K., Hasan, R., Kowalska, D. B., Desai, A., & Bergese, S. D. (2024). Dysmenorrhea, a narrative review of therapeutic options. Journal of Pain Research, 17, 2657–2674. https://doi.org/10.2147/JPR.S459584
Bagley, E. E., & Ingram, S. L. (2020). Endogenous opioid peptides in the descending pain modulatory circuit. Neuropharmacology, 173, Article 108131. https://doi.org/10.1016/j.neuropharm.2020.108131
Reis, C. A. A. S., Hardy, E., & Sousa, M. H. (2010). The effectiveness of connective tissue massage in the treatment of primary dysmenorrhea among young women. Revista Brasileira de Saúde Materno Infantil, 10(2), 247–256. https://doi.org/10.1590/S1519-38292010000200012
Yadav, S., Joshi, S., & Punia, S. (2024, October). Efficacy of combined exercise training during different menstrual phases in young students with primary dysmenorrhea. Physiotherapy Research International, 29(4), e2131. https://doi.org/10.1002/pri.2131
Zheng, Q., Huang, G., Cao, W., & Zhao, Y. (2024). Comparative effectiveness of exercise interventions for primary dysmenorrhea: a systematic review and network meta‑analysis. BMC Women’s Health, 24, Article 610. https://doi.org/10.1186/s12905-024-03453-w
Kawabe, R., Chen, C. Y., Morino, S., Mukaiyama, K., Shinohara, Y., Kato, M., Shimizu, H., Shimoura, K., Nagai‑Tanima, M., & Aoyama, T. (2022). The relationship between high physical activity and premenstrual syndrome in Japanese female college students. BMC Sports Science, Medicine and Rehabilitation, 14, Article 175. https://doi.org/10.1186/s13102-022-00569-0
Deodato, M., Grosso, G., Drago, A., Martini, M., Dudine, E., Murena, L., & Buoite Stella, A. (2023, October). Efficacy of manual therapy and pelvic floor exercises for pain reduction in primary dysmenorrhea: A prospective observational study. Journal of Bodywork and Movement Therapies, 36, 185–191. https://doi.org/10.1016/j.jbmt.2023.07.002
Armada-Dias, L., de Oliveira, A. M., Maia, R. R. P., de Queiroz, M. G. R., da Silva, J. C., da Silva, A. L. C., & Ferreira, M. B. G. (2019). Acupressure in the control of primary dysmenorrhea: Randomized clinical trial. Complementary Therapies in Clinical Practice, 34, 47–52. https://doi.org/10.1016/j.ctcp.2018.07.007
López‑Liria, R., Torres‑Álamo, L., Vega‑Ramírez, F. A., García‑Luengo, A. V., Aguilar‑Parra, J. M., Trigueros‑Ramos, R., & Rocamora‑Pérez, P. (2021). Efficacy of physiotherapy treatment in primary dysmenorrhea: A systematic review and meta‑analysis. International Journal of Environmental Research and Public Health, 18(15), 7832. https://doi.org/10.3390/ijerph18157832
Azima, S., Bakhshayesh, H. R., Kaviani, M., Abbasnia, K., & Sayadi, M. (2015). Comparison of the effect of massage therapy and isometric exercises on primary dysmenorrhea: A randomized controlled clinical trial. Journal of Pediatric and Adolescent Gynecology, 28(6), 486–491. https://doi.org/10.1016/j.jpag.2015.02.003
Crichton, M., Marshall, S., Marx, W., Isenring, E., & Lohning, A. (2023, January 23). Therapeutic health effects of ginger (Zingiber officinale): Updated narrative review exploring the mechanisms of action. Nutrition Reviews. Advance online publication. https://doi.org/10.1093/nutrit/nuac115
Chandrakirana Krisnamurti, G., & Fatchiyah, F. (2020). The biological function prediction of the 10‑gingerol compound of ginger in inhibiting cyclooxygenase-2 activity. Journal of Pure and Applied Chemistry Research, 9(3), 222–232. https://doi.org/10.21776/ub.jpacr.2020.009.03.547
Crichton, M., Davidson, A. R., Innerarity, C., Marx, W., Lohning, A., Isenring, E., & Marshall, S. (2022). Orally consumed ginger and human health: An umbrella review. American Journal of Clinical Nutrition, 115(6), 1511–1527. https://doi.org/10.1093/ajcn/nqac035
Al‑Suhaimi, E. A., Al‑Riziza, N. A., & Al‑Essa, R. A. (2011). Physiological and therapeutical roles of ginger and turmeric on endocrine functions. The American Journal of Chinese Medicine, 39(2), 215–231. https://doi.org/10.1142/S0192415X11008762
Kashefi, F., Khajehei, M., & Tabatabaeichehr, M. (2014). Comparison of the effect of ginger and zinc sulfate on primary dysmenorrhea: A placebo‑controlled randomized trial. Pain Management Nursing, 15(4), 826–833. https://doi.org/10.1016/j.pmn.2013.09.001
Salmon, C. N. A., Bailey‑Shaw, Y. A., Hibbert, S., Green, C., Smith, A. M., & Williams, L. A. D. (2012). Characterisation of cultivars of Jamaican ginger (Zingiber officinale Roscoe) by HPTLC and HPLC. Food Chemistry, 131(4), 1517–1522. https://doi.org/10.1016/j.foodchem.2011.09.115
Daily, J. W., Zhang, X., Kim, D. S., & Park, S. (2015, December). Efficacy of ginger for alleviating the symptoms of primary dysmenorrhea: A systematic review and meta‑analysis of randomized clinical trials. Pain Medicine, 16(12), 2243–2255. https://doi.org/10.1111/pme.12853
Ozgoli, G., Goli, M., & Moattar, F. (2009). Comparison of effects of ginger, mefenamic acid, and ibuprofen on pain in women with primary dysmenorrhea. Journal of Alternative and Complementary Medicine, 15(2), 129–132. https://doi.org/10.1089/acm.2008.0311
Ali, B. H., Blunden, G., Tanira, M. O., & Nemmar, A. (2008). Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): A review of recent research. Food and Chemical Toxicology, 46(2), 409–420. https://doi.org/10.1016/j.fct.2007.09.085
Views:
24
Downloads:
16
Copyright (c) 2025 Karolina Kananowicz, Patryk Heryć, Zuzanna Kudlińska, Honorata Juniewicz, Ryszard Łagowski, Julia Kosęda, Anna Jędrasiak, Zofia Laska, Marianna Latour, Jakub Piotrowski
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
